Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 47 for “"Remdesivir"”.
-
Untersuchung der Nephrotoxizität von Remdesivir \(in\) \(vitro\)
… Sicherheitsbedenken bezüglich der Anwendung von Remdesivir bei Covid-19-Patienten mit der Gefahr von Nierenfunktionsstörung bis hin zum Nierenversagen im Vergleich zu anderen antiviralen Substanzen, wurde hier der Mechanismus der Toxizität von Remdesivir in vitro an den Nierenzelllinien NRK-52E …
-
Association Between Use of Remdesivir and Bradycardia
Remdesivir received the first emergency use authorization from the FDA for the treatment of COVID-19. Multiple adverse drug reactions (ADR) have been reported since its approval in October 2020. Bradycardia, defined by a decrease in heart rate has been reported as an adverse event for patients …
-
Remdesivir in the treatment of SARS-CoV-2
… infected patients. A drug that was found was remdesivir, which is a nucleotide analog RNA polymerase inhibitor that was originally used for the treatment of Ebola. With FDA emergency approval on May 1st, 2020, remdesivir was used to treat hospitalized COVID19 patients, but at that time the …
-
Liposomal delivery of Remdesivir for localized and targeted treatment of COVID-19
Liposomal delivery of Remdesivir for localized and targeted treatment of COVID-19 COVID-19 is a serious, and in many cases lethal, disease that is caused by infection of the upper respiratory tract by the novel betacoronavirus, SARS-Cov-2 virus. This disease has a very high mortality rate and has …
-
Differential Effects of Remdesivir and Lumacaftor on Homomeric and Heteromeric hERG Channels
… In this study, the rescue effects of two drugs, remdesivir and lumacaftor, on trafficking defective mutant hERG channels were studied by applying patch clamp, Western blot, immunocytochemistry, and Quantitative Reverse Transcription PCR techniques. As our lab has recently reported that the …
-
Comparing the effects of Remdesivir and Hydroxychloroquine in COVID-19: A Meta-Analysis Study
… treatment options. Hydroxychloroquine (HCQ) and remdesivir (RDV), two drugs which have been used previously to treat other illnesses, were repurposed as treatment options for COVID-19. This has led the US Food and Drug Administration to approve both drugs for emergency use authorization. My paper …
-
A Computational study of clades and drug adaptation to remdesivir in SARS-CoV-2
… The third chapter focused on drug adaptation to remdesivir in SARS-CoV-2 in vitro. The collaborator in Frankfurt cultured two strains of the virus until it adapted to remdesivir, and genomic sequencing was performed by Public Health England. By comparing the genomic data between the resistant …
-
Cost Effectiveness Analysis of Remdesivir in COVID-19 Patients at a Large Academic Medical Center
… Chapter three includes an adaptation of the remdesivir CEA model published by the Institute for Clinical and Economic Review (ICER) to examine the incremental cost required to gain one unit of health benefit, or per quality-adjusted life year (QALY), from the hospital perspective. The adapted …
-
Effects of COVID-19 drugs chloroquine, hydroxychloroquine, azithromycin and remdesivir on hERG expression and function
… hydroxychloroquine, azithromycin and remdesivir on hERG and KCNQ1+KCNE1 channel function. My results show that chloroquine and hydroxychloroquine acutely blocked IhERG with an IC50 of 3 µM, and 23.4 µM respectively. Azithromycin and remdesivir did not acutely effect IhERG. When these …
-
Using in vitro gastrulation models to assess the teratogenicity of antiviral drugs: dolutegravir and remdesivir
… both dolutegravir, the anti-HIV medication, and remdesivir, the only FDA-approved treatment for COVID-19, caused significant morphological and molecular changes in the gastrulation model when cell aggregates were exposed to therapeutically relevant concentrations of the drugs. These results …
-
Ανάλυση κόστους - αποτελεσματικότητας της προσθήκης anakinra στη θεραπεία με remdesivir και dexamethasone σε COVID-19 νοσηλευόμενους ασθενείς.
… προσθήκης anakinra στην τυπική θεραπεία (SoC) με remdesivir και dexamethasone, σε ασθενείς που νοσηλεύονται για COVID-19 λοίμωξη. Μεθοδολογία: Αυτή η οικονομική αξιολόγηση συνέκρινε το κόστος και την αποτελεσματικότητα 28 ημερών για τρεις ομάδες COVID-19 νοσηλευόμενων ασθενών, (1) ομάδα Α που …
-
Structural analysis of the SARS-CoV-2 exonuclease domain for the development of a resistant nucleotide analog inhibitor
… nucleoside analogs, and one such antiviral is remdesivir, an adenosine analog that was approved for emergency use during the pandemic. However, the efficacy of remdesivir in clinical trials was much lower than in vitro studies. It was proposed that the unique coronavirus proofreading …
-
Characterization of Novel Testis Specific ACTRT2 and ACTRT3 in Mammalian Spermatogenesis and Toxicological Profile of Remdesivir in Male Fertility Outcomes Using Animal Model
… the safety profile of the antiviral drug Remdesivir in mice through IP and IV exposure routes and determined its effects on spermatogenesis and fertility. This information will be valuable in understanding the off-target effects of pharmaceuticals and their impact on male fertility. …
-
Biochemical mechanisms for selectivity governing RNA and DNA replication
… genome in less than 2 minutes. The ATP analog Remdesivir triphosphate, the only FDA approved treatment for COVID-19, was then studied to calculate the discrimination relative to ATP. We found that Remdesivir is incorporated more efficiently than ATP and acts as a delayed chain terminator, …
-
Competing risks analysis for a COVID-19 clinical trial
… Treatment Trial, evaluating the effect of remdesivir treatment on time to death and time to discharge. We estimated the cumulative incidence functions of time to death and time to discharge, stratified by treatment arm and additionally by ventilation history to understand treatment effect …
-
Secondary Use of Electronic Health Record to Assess the Recognition, Risk Factors and Outcomes of the Acute Kidney Injury in Hospitalized Adult Patients
… particularly interested in the nephrotoxicity of Remdesivir (intravenous route). We analyzed the role of remdesivir and built multifactorial causal models of COVID-AKI by applying causal discovery machine learning techniques. Our models successfully recreated known causal pathways to changes in …
-
Bundibugyo Versus Zaire Ebolaviruses: Examination of the Polymerase Complex as a Therapeutic Target
… inhibitors, of which the nucleoside analog remdesivir emerged as a lead candidate. Remdesivir was found to be highly effective at inhibiting primary transcription, and delayed treatment required a significantly higher concentration. Use of remdesivir was more effective at inhibiting BDBV …
-
From Cardiovascular Safety Assessment to Peptide Hemolytic Activity Prediction: Integrative Computational Analyses for Drug Evaluation and Discovery
… events associated with three COVID-19 therapies, remdesivir, Paxlovid, and REGEN-COV. Remdesivir showed the strongest and most consistent cardiovascular safety signals, particularly for bradycardia, hypotension, and cardiac arrest. Age-stratified analyses indicated distinct age-associated …
-
Structures, Functions, and Druggability of the SARS-CoV-2 Replication–Transcription Complex
… a target for clinically used antivirals such as remdesivir and molnupiravir. Faithful synthesis of viral RNAs by the RTC requires recognition of the correct nucleotide triphosphate (NTP) for incorporation into the nascent RNA, while antiviral nucleoside analogs must compete with the natural NTPs …
Page 1 of 3